Donor CMV serostatus has no impact on CMV viremia or disease when prophylactic granulocyte transfusions are given following allogeneic peripheral blood stem cell transplantation.

Ravi Vij; John F DiPersio; Partha Venkatraman; Kathryn Trinkaus; Lawrence T Goodnough; Randy A Brown; Hanna J Khoury; Steven M Devine; Aarti Oza; Shalini Shenoy

doi:10.1182/blood-2002-07-2110

Donor CMV serostatus has no impact on CMV viremia or disease when prophylactic granulocyte transfusions are given following allogeneic peripheral blood stem cell transplantation.

Identifier:nobleid.org/w1/20260515/FF3C2F85

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/FF3C2F85.svg?ark=w1%2F20260515%2FFF3C2F85)](https://nobleid.org/work/w1/20260515/FF3C2F85)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Donor CMV serostatus has no impact on CMV viremia or disease when prophylactic granulocyte transfusions are given following allogeneic peripheral blood stem cell transplantation.

Identifier:nobleid.org/w1/20260515/FF3C2F85

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/FF3C2F85.svg?ark=w1%2F20260515%2FFF3C2F85)](https://nobleid.org/work/w1/20260515/FF3C2F85)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work